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Abstract 
Induced pluripotent stem cells (iPS cells) exhibit unique properties similar to embryonic stem cells (ES cells). A central feature of 
iPS cells is their pluripotency: they have the potential of growing indefinitely and differentiating into all cell types of the human 
body. Therefore, essentially unlimited numbers of somatic cells might be generated. Until now, there is a paucity of industrial 
processes for large scale production of human iPS cells and their differentiated progeny. This is mostly due to the high complexity 
of the manual processes, which are involved in the production of these cells. To take full advantage of the potential of iPS cell 
technology there is the need to produce iPS cell lines in high numbers, by employing automation, high throughput techniques and 
standardized protocols. Therefore we set up a large scale research project to develop a novel automatic production unit for 
reprogramming, cultivation and differentiation of iPS cells. A key step within the process chain is the automatic selection of 
primary iPS cell colonies in the culture dish. Within this study central elements of the automation process and quality control are 
presented. 
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1. Introduction 
The potential of induced pluripotent stem cells (iPS 
cells) provides novel opportunities for generating 
essentially unlimited numbers of patient and disease-
specific cells. Thus, iPS cell technology opens up new 
perspectives to test and validate novel drugs for hitherto 
incurable neurodegenerative or cardiac diseases directly 
in human cells. In the long term, iPS cell-based neuronal 
and cardiac cells may also be used as autologous source 
in cell replacement therapy. These exciting new 
biomedical perspectives demand for technologies to 
generate iPS cells and their differentiated progeny, such 
as neuronal and cardiac cells, in large quantities in a 
standardized and industrial format.  
Until now there is a deficiency in industrial processes 
for large scale production of human iPS cells for drug 
development. One reason is the high complexity of the 
manual processes involved and the need for highly 
qualified and experienced laboratory staff. The 
adaptation of iPS cell production to industrial formats 
and automatic process steps for high throughput 
screening (HTS) has remained a major challenge. 
Established biotechnological methods aim for a large 
scale production of one specific cell type. The iPS cell 
technology however demands the production, generation 
and differentiation of large numbers of individual iPS 
cell clones with the respective quality control. The 
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transfer of manual laboratory processes for 
reprogramming, selection and expansion to an automatic 
production process requires innovative solutions when it 
comes to the system control unit. A major challenge is 
the systematic parallelization of all biotechnological 
production steps. 
A critical step for the entire process chain for 
generation of clonal iPS cell lines is the automatic 
selection of primary iPS cell colonies in the culture dish. 
Frequently, morphology of the colonies are analyzed by 
phase contrast microscopy. Additionally, fluorescence-
based life cell imaging methods are used to detect 
pluripotency-associated markers. The robotic units being 
developed allow the purification and sorting of the 
detected iPS cells and are fully integrated into the 
production system. Within the framework of this project, 
we present initial data on how to automate the complex 
manual process steps for reprogramming, cultivation and 
differentiation of human iPS cells. 
2. Methods 
2.1. Reprogramming of primary fibroblasts to iPS cells 
iPS cells exhibit unique properties similar ES cells. 
iPS cells are pluripotent: they have the ability to grow 
indefinitely and differentiate into all cells of the human 
body [1,2]. Frequently, iPS cells are generated by 
reprogramming of somatic cells, such as fibroblasts, 
towards pluripotency. This is achieved by targeted 
delivery of a specific set of reprogramming factors, 
including the transcription factors Oct4, Sox2, c-Myc 
and Klf4. 25 days later emerging iPS cells are isolated 
by mechanically picking individual colonies, which are 
further expanded under specific culture conditions with 
the growth factor bFGF. As shown in Figure 1, iPS cells 
show ES cell-like morphology, express a panel of 
specific pluripotency markers and exhibit an ES cell-like 
gene expression program. Hence, iPS cell quality is 
assessed by a panel of criteria prior to their expansion 
and use. 
The reprogramming process described here employs 
Sendai virus vectors for delivery of reprogramming 
transcription factors. This delivery system was chosen to 
ensure efficient delivery and expression of 
reprogramming factors without modifying the genome of 
target cells. A specific Sendai virus variant is used to 
allow complete removal of virus vector after successful 
reprogramming [3,4]. The temperature sensitive virus 
variant can be removed from target cells by shifting the 
temperature to 38°C for 5 days.  iPS cells are expanded 
under serum free conditions on specifically coated tissue 
culture surfaces (e. g. Matrigel). With time in culture the 
pluripotent iPS cell phenotype stabilizes, thereby 
yielding homogenous, fully reprogrammed pluripotent 
cell populations. 
 
 
Fig. 1. iPS cell colonies are characterized by a distinct morphology, 
including a “smooth” colony rim. iPS cell differentiation is 
characterized by the loss of rim integrity, gross heterogeneity of cell 
morphology within the colony and the emergence of more 
differentiated cells with alternate cell shapes. (a) Human iPS cell 
colony with ES cell-like morphology grown on matrigel exhibits a 
well-defined rim; (b) Human iPS cell colony with large area of 
differentiated cells in the left part of the image. 
When viewed by phase contrast microscopy 
undifferentiated human iPS cells grow as compact, 
multicellular colonies, as shown in Figure 1. Cells also 
exhibit a high nuclear-to-cytoplasm ratio and prominent 
nucleoli. These colonies are characterized by a distinct 
”smooth” rim. iPS cell differentiation is associated with 
loss of rim integrity, gross heterogeneity of cell 
morphology within the colony and an increase of 
differentiated cells, exhibiting a large variety of cell 
morphologies. 
2.2. Automation of the iPS cell culture process 
The challenge in automation of the iPS cell culture 
process lies in the complexity and the long cultivation 
periods [5]. Starting point of the process analysis are 
flow charts describing the (i) manual process, (ii) the 
materials that are used and (iii) the general requirements. 
The next step is to merge the workflows and select 
devices for each process-cluster that are suited for the  
automation. After defining all disposable formats, a draft 
of the machine concept, including all automation steps, 
is designed. Additionally, non-deterministic processes, 
like iPS cell generation, require highly flexible handling 
systems, such as articulated robots. In an iterative 
procedure, process and machine concept are optimized 
in detail.  
The next phase of developing the automated system 
for iPS cell generation is the detailed design of the 
machine including main frame and enclosure. Based on 
the layout of the lab devices all handling systems are 
specified. Collision analysis of all handling operations is 
essential to avoid extensive corrections during the 
implementation. To ensure the effectiveness of these 
methods the machine design follows hygienic guidelines 
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and is optimized for targeted air flow. To handle the 
complexity of the production unit, a customized control 
software is being developed. The key to reduce  
complexity is to divide the process into small unique 
workflows that are handled without interaction. To allow 
efficient automated scheduling, process data, e.g. 
duration, material or, devices, is added to each 
individual workflow. 
2.3. Criteria for iPS cell quality 
Frequently, iPS cell quality is assessed by a panel of 
criteria: ES cell-like morphology, expression of 
pluripotency markers by immunofluorescence (Tra-1-60, 
Tra-1-81, SSEA-4, Oct4), alkaline phosphatase staining, 
differentiation potential in embryoid body (EB) assays 
and teratoma formation in immune-deficient mice. These 
criteria have been extended by evaluating the genome-
wide gene expression profile of iPS cells by DNA 
microarrays and specific software packages (e. g. 
PluriTest; [6]). 
In the automated production system for primary iPS 
cells a high quality standard is maintained by several 
measurement technologies to monitor cell growth and to 
detect potential contaminations as early as possible. 
Further live cell imaging techniques are linked with 
customized image processing algorithms to allow 
efficient quality control processes.      
3. Results 
3.1. Automated reprogramming of primary fibroblasts 
The prototype production unit is designed to generate 
up to 60 different iPS cell lines in parallel.  From donor 
material to end product the reprogramming process takes 
up to ten weeks. To allow the necessary flexibility the 
operator can either start all cell culture processes 
manually or use a scheduler. The machine includes 
following main modules. 
The border between operator and machine is a 5.30m 
x 2.60m x 2.80m housing, as seen in Figure 2, with 18 
electrically lockable doors for good operator 
accessibility. Via the laminar flow system in the ceiling 
of the housing sterile air is continually blown 
downwards to ensure biological product and operator 
safety. 
For fast and flexible handling, a KR5 sixx 850 CR 
Kuka (Germany) robot is used, which is installed on a 
linear transport slide to cover the whole operating area 
with a seize of 4m x 1.5m as seen in Figure 3. With a 
servo-electric gripper and a collision sensor from PTM 
(Germany), reliable material transport is guaranteed. The 
robot is not only suited for transport but also to perform 
complex movements, like pivoting of tubes and plates 
for liquid mixing. To ensure correct handling of tissue 
culture plates a 1D / 2D barcode scanner is integrated.  
Material transfer between machine and lab-
environment is realized via aerodynamically separated 
locks. These locks with integrated cooling systems are 
loaded by the operator with up to 2600 disposable 
pipette tips, 75 multi well plates, 100 centrifuge tubes 
and 16 media bottles. Liquid waste and used disposables 
are automatically disposed in a separated area, which has 
an additional aspiration system to avoid contamination. 
All liquid handling tasks are executed by a gantry 
robot from HiTec Zang (Germany), which uses 
disposable pipette tips and detects fluid levels via an 
ultrasonic sensor. For automated media refill, pressure 
based fluidics and a heating system are integrated. 
 
Fig. 2. Machine enclosure with laminar flow (right), external control 
system (left) and external incubator (left back) 
 
Fig. 3. View without enclosure: liquid handling area (yellow), lock 
area (red), process and quality control area (blue) 
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3.2. Automated quality control 
For process and quality control several measurement 
devices are integrated into the automated production 
system. Both, commercially available devices as well as 
customized and specifically developed systems are 
integrated to provide an effective process and quality 
control. 
3.2.1. Automated microscope 
The main instrument for evaluation of cell colonies 
throughout the process is an inverted research 
microscope (Nikon Ti-E, Japan). The microscope is fully 
automated and provides bright-field, phase contrast and 
fluorescence imaging with magnifications ranging from 
4x to 20x. The microscope automation includes (i) 
choice of objectives, (ii) setting of required phase rings, 
(iii) controlling of intensity of light sources and (iv) 
setting of wavelengths and filters required for 
fluorescence imaging. For fluorescence measurements 
three wavelengths (365, 470 and 565 nm) together with 
ET filter sets for EGFP, Texas Red and DAPI are 
implemented. LED light sources are used due to the 
longer life time.  
The graphical software environment LabVIEW is 
employed to control the microscope and to communicate 
with the overall control level by means of web services 
(RESTful architecture) [7]. This communication scheme 
is used in a similar manner with the other measurement 
devices, which are integrated into the production system. 
The microscope images are analyzed by image 
processing methods (e.g. determination  of confluence or 
colony morphology)  
3.2.2. Cell counting device 
For determining cell numbers and assessing the 
overall state of cell culture, we use the automated, 
image-based Cedex HighRes (Roche, Switzerland). The 
measurement method of this device is based on Trypan 
Blue Exclusion [8] and provides information about cell 
density, viability, aggregation rate, morphology and 
amount of cell debris in cell samples.  
3.2.3. Camera station 
For a macroscopic overview of cell cultures a camera 
station was developed, which allows precise positioning 
of microtiter plates in a LED background illumination 
and high resolution image acquisition. Photos are used 
for documentation to detect abnormalities, like yeast or 
fungi contaminations. Furthermore, the pH of the culture 
medium  is read out by processing the color change of 
the phenol red indicator.  
3.2.4. Photometer 
Potential contaminations in cultures are detected by 
measurement of turbidity. This is achieved by measuring 
the absorbance with the spectrometer based microplate 
reader FLUOstar Omega (BMG Labtech, Germany).  
3.2.5. Cell harvesting device  
A key process of the automation is the harvesting of 
pluripotent cell colonies, which are subsequently further 
expanded to establish iPS cell lines. For automated 
colony detection and harvesting the AVISO CellCelector 
(Germany) is used [9]. This device is a freely 
configurable tool for automated transfer of single cells 
and cell colonies, which employs a harvest process with 
a gentle cell uptake directly from culture plates without 
enzymatic pre-treatment. Using this technology, high 
survival rates and cell integrity are achieved. The 
harvesting process is supported by an inverted 
microscope that offers phase contrast, bright field 
observation and fluorescence illumination. The selection 
process is based on image processing algorithms that 
detect the colonies to be picked and transferred.  
 
4. Conclusion & Discussion 
In this study we present data on developing an 
automatic production process for human iPS cells. 
Technological challenges are addressed by integrating 
smart monitoring solutions for detecting the cellular 
conditions and quality throughout the entire production 
process. By developing a transfer method from manual 
to automatic process protocols, a systematic approach is 
achieved. The project is currently at an early stage of its 
development. Reports on process and biotechnological 
efficacy are planned once the sterile cell culture process 
is running.  
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